Kyverna Therapeutics, Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.64-$30.60
Market Cap
$120M
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$96.1M
Diluted EPS
-$2.96

News

See more

Yahoo Finance • 16 days ago

Investors in Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX

Yahoo Finance • 17 days ago

Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX

Yahoo Finance • 17 days ago

DEADLINE ALERT for KYTX, SUI, MGPI, APLT Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Yahoo Finance • 17 days ago

KYTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action – KYTX

About

CEO
Mr. Warner Biddle
Address
5980 Horton Street, Emeryville, CA, United States, 94608
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
119